Global News

INC Research appoints Judith Ng-Cashin chief scientific officer

Monday, March 14, 2016

INC Research, a, global phase I to IV CRO, has appointed Judith Ng-Cashin, M.D., as chief scientific officer. Dr. Ng-Cashin will lead the integration of the Company’s industry-recognized therapeutic and medical/scientific expertise for phase I to IV clinical trials. She will be responsible for scientific, medical and ethical governance matters, including collaboration with key medical and scientific stakeholders to strengthen INC’s position as a collaborative partner to clinical practice, sponsor and academic organizations.

[Read More]

Greenphire appoints Wayne Baker chief commercial officer

Monday, March 14, 2016

Greenphire, a global clinical payment solutions provider, has appointed Wayne Baker as chief commercial officer to lead the commercial strategy of the rapidly growing organization worldwide. Wayne brings more than 25 years of global commercial experience in technology and life science industries, most recently serving as the senior vice president and chief sales officer at Advanced Health Media (AHM).

[Read More]

Logistics issues in clinical trials

Monday, March 14, 2016

The Pulse on Global Trials by Matthew Howes

Most industry experts estimate that supply chain logistics for clinical trials account for 20 to 25% of total R&D costs. There is evidence that those estimates are growing. EvaluatePharma reports that logistics services are experiencing a growth rate of 12%, which is faster than the more stable overall market growth of 2 to 2.5%. With rising cost pressures from payers and policy makers worldwide, it is surprising that more attention has not been paid to this increasingly dominant factor in clinical development.

[Read More]

Clintrax Global joins WIRB-Copernicus Group

Thursday, March 10, 2016

Clintrax Global has joined the WIRB-Copernicus Group (WCG) family of companies. WCG is a leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that. Founded by former biopharmaceutical and CRO attorneys, Clintrax Global provides outsourced services for negotiating clinical trial-related contracts and budgets between biopharmaceutical companies, CROs and investigator sites around the world. Clintrax Global also manages, executes, and tracks payments between these global clinical trial participants.

[Read More]

Vaxart begins oral Zika virus vaccine testing

Tuesday, March 8, 2016

Vaxart, a clinical stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, has initiated preclinical testing of an oral vaccine for Zika virus. With no available vaccine or treatment modalities, the World Health Organization (WHO) recently declared Zika virus an international public health emergency.

[Read More]